S100A8 and essential thrombocythemia: They found that the sensitivity and specificity of S100A8/A9 are higher among PV, ET, and PMF patients than the well-known inflammatory marker, C reactive protein (CRP), which makes S100A8/A9 a useful diagnostic biomarker.